Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Back to the forum  2018-07-23 00:23 CEST (UTC+2h)

Levothyroxine Sample size and study design [Power / Sample Size]

posted by lakshmiprasad - India, 2018-04-11 15:09  - Posting: # 18666
Views: 1,121

Dear All,

I would like to Know that regarding the sample size for levothyroxine sodium, I had gone through the all available literature's for sample size the levothyroxine sodium ISCV was found the below 18%. But the sample size was taken 72 or more than 50. if CV is below the 18% THEN what is the reason behind to considered 70 subjects:confused:.

Even OGD also It was mentioned as design is fully replicate but all literature's it was mentioned 2 way cross over.

I am thinking due to base line correction, this molecule will show any more variability?

Please guide me levothyroxine is variable drug or not.

if it was not variable in literature why it was mentioned 72 subjects.


thanks & Regards

N. L. D. Prasad

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,547 posts in 3,941 threads, 1,190 registered users;
online 12 (0 registered, 12 guests [including 9 identified bots]).

[The] impatience with ambiguity can be criticized in the phrase:
absence of evidence is not evidence of absence.    Carl Sagan

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed